Table 1. Characteristics of antidiabetic drugs in patients with DM history (n = 46).
| Characteristics | At admission | During in-hospital stay | On discharge |
|---|---|---|---|
| T2DM, n (%) | 45 | - | - |
| T1DM, n (%) | 1 | - | - |
| Insulin use, n (%) | 8 (17.3) | 34 (73.9) | 30 (65.2) |
| Sulphonyl urea, n (%) | 2 (4.3) | - | - |
| Biguanides, n (%) | 31 (67.3) | - | - |
| DPP-4 inhibitors, n (%) | 21 (45.6) | 12 (26.0) | 12 (26.0) |
| GLP-1 receptor agonist, n (%) | 8 (17.3) | - | - |
| SGLT-2 inhibitors, n (%) | 13 (28.2) | - | - |
| No treatment | 4 (8.7) | - | - |
Data are presented as means ± SD.
T2DM, type 2 diabetes mellitus; T1DM, type 1 diabetes mellitus; DPP-4, dipeptidyl peptidase 4; GLP-1, glucagon-like peptide 1; SGLT-2, sodium glucose co-transporter-2